Baidu
map

Current Biology:帕金森病竟由于神经细胞过劳死?

2015-09-01 chenshuo 译 MedSci原创

加拿大蒙特利尔大学的研究人员认为,帕金森病可能是因为经常消耗大量能量,导致脑细胞出现能量危机。这场危机使细胞过热,结果导致细胞本身的损伤。并将研究结果发表在Current Biology。药理学和神经科学教授Louis-Éric Trudeau耗时17年研究帕金森病、精神分裂症和药物成瘾患者的大脑。他认为,就像一个电机在高速运行,这些神经元细胞需要产生巨大的能量来运转。因此它们会尽早地使自己衰竭并

加拿大蒙特利尔大学的研究人员认为,帕金森病可能是因为经常消耗大量能量,导致脑细胞出现能量危机。这场危机使细胞过热,结果导致细胞本身的损伤。研究结果发表在Current Biology。


药理学和神经科学教授Louis-Éric Trudeau耗时17年研究帕金森病、精神分裂症和药物成瘾患者的大脑。他认为,就像一个电机在高速运行,这些神经元细胞需要产生巨大的能量来运转。因此它们会尽早地使自己衰竭并凋亡。这将会对今后研发治疗药物具有意义,以帮助相应神经元细胞合理有效地使用资源,从而减少对自身的损害。

帕金森病是由于大脑中的一些区域病变如黑质神经细胞的死亡。帕金森病患者神经细胞释放多巴胺量减少,会导致患者出现相应症状,如震颤、缓慢、僵硬和平衡失调等表现。

3年来,研究人员一直在探究为什么帕金森病患者脑部一些区域的神经细胞中的线粒体会出现超负荷,他们发现,在这些区域的细胞具有非常复杂的结构,会释放许多化学信使使细胞时刻处于高代谢、高能状态。Trudeau教授指出,他们的研究及产出的相应药物能使相应神经元细胞的线粒体减轻负荷。“跟一个电机相似,”教授说,“一辆汽车的电机如果过热就会燃烧更多的燃料,因此,这辆汽车也不能使用很久。”

随着我们年龄的增长,细胞结构的复杂性也会使脑细胞变得脆弱,它们更容易出现损伤和死亡,因此易导致引发帕金森病。

因此,药物研发十分重要。同时需要采取更进一步的研究,以便为帕金森病患者带来更多希望。

原始出处:

Consiglia Pacelli et al.Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons.Current Biology.27 August 2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=287075, encodeId=a59e28e075b0, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Feb 11 11:40:07 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654151, encodeId=4d991654151ff, content=<a href='/topic/show?id=fb1c93983c3' target=_blank style='color:#2F92EE;'>#过劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93983, encryptionId=fb1c93983c3, topicName=过劳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33cb24457942, createdName=qilu_qi, createdTime=Sat Oct 31 22:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917187, encodeId=058a191e187f0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Mar 24 12:00:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766960, encodeId=4d301e66960f3, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Feb 05 15:00:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489521, encodeId=cb461489521c2, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Sep 02 15:00:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]
    2018-02-11 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=287075, encodeId=a59e28e075b0, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Feb 11 11:40:07 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654151, encodeId=4d991654151ff, content=<a href='/topic/show?id=fb1c93983c3' target=_blank style='color:#2F92EE;'>#过劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93983, encryptionId=fb1c93983c3, topicName=过劳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33cb24457942, createdName=qilu_qi, createdTime=Sat Oct 31 22:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917187, encodeId=058a191e187f0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Mar 24 12:00:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766960, encodeId=4d301e66960f3, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Feb 05 15:00:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489521, encodeId=cb461489521c2, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Sep 02 15:00:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]
    2015-10-31 qilu_qi
  3. [GetPortalCommentsPageByObjectIdResponse(id=287075, encodeId=a59e28e075b0, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Feb 11 11:40:07 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654151, encodeId=4d991654151ff, content=<a href='/topic/show?id=fb1c93983c3' target=_blank style='color:#2F92EE;'>#过劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93983, encryptionId=fb1c93983c3, topicName=过劳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33cb24457942, createdName=qilu_qi, createdTime=Sat Oct 31 22:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917187, encodeId=058a191e187f0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Mar 24 12:00:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766960, encodeId=4d301e66960f3, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Feb 05 15:00:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489521, encodeId=cb461489521c2, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Sep 02 15:00:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]
    2016-03-24 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=287075, encodeId=a59e28e075b0, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Feb 11 11:40:07 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654151, encodeId=4d991654151ff, content=<a href='/topic/show?id=fb1c93983c3' target=_blank style='color:#2F92EE;'>#过劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93983, encryptionId=fb1c93983c3, topicName=过劳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33cb24457942, createdName=qilu_qi, createdTime=Sat Oct 31 22:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917187, encodeId=058a191e187f0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Mar 24 12:00:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766960, encodeId=4d301e66960f3, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Feb 05 15:00:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489521, encodeId=cb461489521c2, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Sep 02 15:00:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=287075, encodeId=a59e28e075b0, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Feb 11 11:40:07 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654151, encodeId=4d991654151ff, content=<a href='/topic/show?id=fb1c93983c3' target=_blank style='color:#2F92EE;'>#过劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93983, encryptionId=fb1c93983c3, topicName=过劳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33cb24457942, createdName=qilu_qi, createdTime=Sat Oct 31 22:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917187, encodeId=058a191e187f0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Mar 24 12:00:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766960, encodeId=4d301e66960f3, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Feb 05 15:00:00 CST 2016, time=2016-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489521, encodeId=cb461489521c2, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Sep 02 15:00:00 CST 2015, time=2015-09-02, status=1, ipAttribution=)]

相关资讯

多巴治疗下的创意涌动:换个角度看帕金森病

近年来有多个研究报道称,帕金森病患者应用多巴治疗后,其艺术创造力剧增[1]。Achinoam Faust-Socher等将其探讨帕金森病患者创造力的文章于2014年发表在ANN NEUROL杂志上,并探讨了这种创造力是否与冲动控制障碍一样是多巴治疗的并发症[2]。 他们对27例接受多巴受体激动剂和/或左旋多巴治疗的右利手帕金森病患者和27例年龄、性别、教育程度相匹配的健康志愿者进行认知、

Neurology:熊去氧胆酸可治疗帕金森病

谢菲尔德转化神经科学研究所的研究人员(SITraN)和约克大学的学者合作开展的一项研究表明,为携带有突变LRRK2基因(引起遗传性帕金森病的最常见原因)的果蝇注入熊去氧胆酸(UDCA)后治疗效果很突出。他们并将研究结果发表在Neurology。“我们发现UDCA治疗LRRK2基因携带者(包括无症状LRRK2携带者)很有效果,”SITraN的Heather Mortiboys博士说道,“对于有症状和

PNAS:氯喹具有治疗帕金森病作用

新加坡与美国科学家研究发现,两种使用数十年的抗疟疾药物,有望成为帕金森症患者可使用的新疗法。医疗界目前没有任何可以有效延缓病状,或完全根治帕金森症的方法。新加坡的南洋理工大学科研人员与美国哈佛大学医学院附属麦克莱恩医院科研人员进行的动物实验发现,两个已经具有好几十年应用历史的抗疟疾药物氯喹(chloroquine)和阿莫地喹(amodiaquine),可以刺激大脑神经细胞,保护黑质神经元产生多巴胺

Plos Medicine:可控风险因素和阿尔兹海默症的关联

全球存在大约四千万老年痴呆症患者,而且数量还有增加的趋势,据估计到2050年全球将会有1.5亿老年痴呆患者。这些老年患者往往表现为记忆力下降,交流障碍和认知功能障碍。在这些老年痴呆患者中,最常见的是阿尔兹海默症(AD),大约占到60%-70%。研究者们一直在试图寻找AD的成因,尤其是那些可能的可控风险因素,因为通过控制这些因素可能可以降低AD的发病率。流行病学的研究已经发行了几种潜在的风险因素,例

Nature:这么牛?单一蛋白就可引发帕金森疾病及多系统萎缩症的发生

许多神经变性障碍都是由名为α-突触核蛋白的单一蛋白的集聚而引发,近日刊登在国际杂志Nature上的一篇研究论文中,来自安特卫普大学(University of Antwerp)等处的研究人员通过揭示了这些聚集物的结构及形状,同时研究者还发现这些聚集物可以决定个体是否患帕金森疾病或多系统萎缩症。典型的神经变性疾病就是大脑细胞间交流被打断同时还会引发特殊大脑区域出现细胞的缺失,对于某些大脑疾病而言这种

中国一天一次的抗帕金森病治疗药物获批上市

一天只需服用一次的抗帕金森病治疗药物--普拉克索缓释片正式在我国上市,为我国抗帕金森病疾病领域带来首个一天一次的治疗方案。中华医学会神经病学分会常委、中国医师协会神经内科医师分会副会长兼帕金森病与运动障碍专业委员会副主任委员、北京医院神经内科主任陈海波教授表示:普拉克索缓释片的上市对帕金森病患者来说,每天只需一次药,治疗更轻松方便,它将使患者更容易坚持长期规范治疗,从而有效控制疾病症状,轻松自如地

Baidu
map
Baidu
map
Baidu
map